AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $113,000 | +82.3% | 15,000 | 0.0% | 0.01% | +80.0% |
| Q3 2019 | $62,000 | +44.2% | 15,000 | 0.0% | 0.01% | +66.7% |
| Q2 2019 | $43,000 | +95.5% | 15,000 | 0.0% | 0.00% | +50.0% |
| Q1 2019 | $22,000 | +214.3% | 15,000 | +9159.3% | 0.00% | +100.0% |
| Q4 2018 | $7,000 | -89.4% | 162 | -98.9% | 0.00% | -80.0% |
| Q3 2018 | $66,000 | -38.3% | 15,000 | 0.0% | 0.01% | -44.4% |
| Q2 2018 | $107,000 | 0.0% | 15,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $107,000 | -13.0% | 15,000 | 0.0% | 0.01% | -18.2% |
| Q4 2017 | $123,000 | -60.8% | 15,000 | -50.0% | 0.01% | -42.1% |
| Q3 2017 | $314,000 | -4.8% | 30,000 | 0.0% | 0.02% | -13.6% |
| Q2 2017 | $330,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |